A citation-based method for searching scientific literature

Adrian Vella, Jennifer L R Freeman, Imogene Dunn, Kit Keller, John B Buse, Carmen Valcarce. Sci Transl Med 2019
Times Cited: 9







List of co-cited articles
50 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dorzagliatin (HMS5552), a novel dual-acting glucokinase activator, improves glycaemic control and pancreatic β-cell function in patients with type 2 diabetes: A 28-day treatment study using biomarker-guided patient selection.
Xiao-Xue Zhu, Da-Long Zhu, Xiao-Ying Li, Ya-Lin Li, Xiao-Wei Jin, Tian-Xin Hu, Yu Zhao, Yong-Guo Li, Gui-Yu Zhao, Shuang Ren,[...]. Diabetes Obes Metab 2018
12
55


Allosteric activators of glucokinase: potential role in diabetes therapy.
Joseph Grimsby, Ramakanth Sarabu, Wendy L Corbett, Nancy-Ellen Haynes, Fred T Bizzarro, John W Coffey, Kevin R Guertin, Darryl W Hilliard, Robert F Kester, Paige E Mahaney,[...]. Science 2003
361
44

Present status of clinical deployment of glucokinase activators.
Akinobu Nakamura, Yasuo Terauchi. J Diabetes Investig 2015
43
44

Modulation of Glucokinase Regulatory Protein: A Double-Edged Sword?
Martijn C G J Brouwers, Chantal Jacobs, Aalt Bast, Coen D A Stehouwer, Nicolaas C Schaper. Trends Mol Med 2015
32
33

Familial hyperinsulinism caused by an activating glucokinase mutation.
B Glaser, P Kesavan, M Heyman, E Davis, A Cuesta, A Buchs, C A Stanley, P S Thornton, M A Permutt, F M Matschinsky,[...]. N Engl J Med 1998
406
33

AMG 151 (ARRY-403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes.
L Katz, N Manamley, W J Snyder, M Dodds, N Agafonova, J Sierra-Johnson, M Cruz, P Kaur, S Mudaliar, P Raskin,[...]. Diabetes Obes Metab 2016
15
33

Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study.
Riccardo C Bonadonna, Tim Heise, Christophe Arbet-Engels, Christoph Kapitza, Angelo Avogaro, Joe Grimsby, Jay Zhi, Joseph F Grippo, Raffaella Balena. J Clin Endocrinol Metab 2010
97
33

Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes.
Gary E Meininger, Russell Scott, Maria Alba, Yue Shentu, Edmund Luo, Himal Amin, Michael J Davies, Keith D Kaufman, Barry J Goldstein. Diabetes Care 2011
123
33

New hope for glucokinase activators in type 2 diabetes?
André J Scheen. Lancet Diabetes Endocrinol 2018
7
42

Novel glucokinase activators: a patent review (2008 - 2010).
Ramakanth Sarabu, Steven J Berthel, Robert F Kester, Jefferson W Tilley. Expert Opin Ther Pat 2011
37
33



Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase.
Kenji Kamata, Morihiro Mitsuya, Teruyuki Nishimura, Jun-Ichi Eiki, Yasufumi Nagata. Structure 2004
329
22

The active conformation of human glucokinase is not altered by allosteric activators.
Pierre Petit, Mathias Antoine, Gilles Ferry, Jean A Boutin, Amandine Lagarde, Laure Gluais, Renaud Vincentelli, Laurent Vuillard. Acta Crystallogr D Biol Crystallogr 2011
40
22


Functional characterization of MODY2 mutations in the nuclear export signal of glucokinase.
Angel Gutierrez-Nogués, Carmen-María García-Herrero, Josep Oriola, Olivier Vincent, María-Angeles Navas. Biochim Biophys Acta Mol Basis Dis 2018
3
66


Discovery of potent and orally active 1,4-disubstituted indazoles as novel allosteric glucokinase activators.
Zacharia S Cheruvallath, Stephen L Gwaltney, Mark Sabat, Mingnam Tang, Haixia Wang, Andy Jennings, David Hosfield, Bumsup Lee, Yiqin Wu, Petro Halkowycz,[...]. Bioorg Med Chem Lett 2017
6
33


α-cell glucokinase suppresses glucose-regulated glucagon secretion.
Davide Basco, Quan Zhang, Albert Salehi, Andrei Tarasov, Wanda Dolci, Pedro Herrera, Ioannis Spiliotis, Xavier Berney, David Tarussio, Patrik Rorsman,[...]. Nat Commun 2018
32
22

Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.
Abd A Tahrani, Anthony H Barnett, Clifford J Bailey. Nat Rev Endocrinol 2016
135
22


Effects of a Novel Glucokinase Activator, HMS5552, on Glucose Metabolism in a Rat Model of Type 2 Diabetes Mellitus.
Ping Wang, Huili Liu, Li Chen, Yingli Duan, Qunli Chen, Shoumin Xi. J Diabetes Res 2017
5
40


Dose-ranging study with the glucokinase activator AZD1656 as monotherapy in Japanese patients with type 2 diabetes mellitus.
A Kiyosue, N Hayashi, H Komori, M Leonsson-Zachrisson, E Johnsson. Diabetes Obes Metab 2013
24
22

Two dose-ranging studies with PF-04937319, a systemic partial activator of glucokinase, as add-on therapy to metformin in adults with type 2 diabetes.
N B Amin, N Aggarwal, D Pall, G Paragh, W S Denney, V Le, M Riggs, R A Calle. Diabetes Obes Metab 2015
18
22

A novel glucokinase activator modulates pancreatic islet and hepatocyte function.
Alexander M Efanov, David G Barrett, Martin B Brenner, Stephen L Briggs, Annie Delaunois, Jim D Durbin, Ulrich Giese, Haihong Guo, Mark Radloff, Gema Sanz Gil,[...]. Endocrinology 2005
96
22

Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study.
Dalong Zhu, Shenglian Gan, Yu Liu, Jianhua Ma, Xiaolin Dong, Weihong Song, Jiao'e Zeng, Guixia Wang, Wenjuan Zhao, Qiu Zhang,[...]. Lancet Diabetes Endocrinol 2018
15
22

Dose-ranging study with the glucokinase activator AZD1656 in patients with type 2 diabetes mellitus on metformin.
J P H Wilding, M Leonsson-Zachrisson, C Wessman, E Johnsson. Diabetes Obes Metab 2013
43
22

Investigational insulin secretagogues for type 2 diabetes.
André J Scheen. Expert Opin Investig Drugs 2016
26
22

Sirt2 facilitates hepatic glucose uptake by deacetylating glucokinase regulatory protein.
Hitoshi Watanabe, Yuka Inaba, Kumi Kimura, Michihiro Matsumoto, Shuichi Kaneko, Masato Kasuga, Hiroshi Inoue. Nat Commun 2018
28
22


Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes.
André J Scheen, Nicolas Paquot, Pierre J Lefèbvre. Expert Opin Investig Drugs 2017
33
22

Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management.
Arun Chaudhury, Chitharanjan Duvoor, Vijaya Sena Reddy Dendi, Shashank Kraleti, Aditya Chada, Rahul Ravilla, Asween Marco, Nawal Singh Shekhawat, Maria Theresa Montales, Kevin Kuriakose,[...]. Front Endocrinol (Lausanne) 2017
269
22

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
S E Inzucchi, R M Bergenstal, J B Buse, M Diamant, E Ferrannini, M Nauck, A L Peters, A Tsapas, R Wender, D R Matthews. Diabetologia 2012
973
22

The potential role of glucokinase activator SHP289-04 in anti-diabetes and hepatic protection.
Lei Lei, Shuainan Liu, Yongqiang Li, Huipeng Song, Lianchao He, Quan Liu, Sujuan Sun, Yan Li, Zhiqiang Feng, Zhufang Shen. Eur J Pharmacol 2018
5
40


Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases.
Ajmer Singh Grewal, Shashikant Bhardwaj, Deepti Pandita, Viney Lather, Bhupinder Singh Sekhon. Mini Rev Med Chem 2016
64
22

Molecular basis for the role of glucokinase regulatory protein as the allosteric switch for glucokinase.
Jung Min Choi, Moon-Hyeong Seo, Hyun-Ho Kyeong, Eunkyung Kim, Hak-Sung Kim. Proc Natl Acad Sci U S A 2013
46
22


Impact of small-molecule glucokinase activator on glucose metabolism and beta-cell mass.
Akinobu Nakamura, Yasuo Terauchi, Sumika Ohyama, Junko Kubota, Hiroko Shimazaki, Tadahiro Nambu, Iseki Takamoto, Naoto Kubota, Junichi Eiki, Narihito Yoshioka,[...]. Endocrinology 2009
49
22

Targeting hepatic glucose metabolism in the treatment of type 2 diabetes.
Amy K Rines, Kfir Sharabi, Clint D J Tavares, Pere Puigserver. Nat Rev Drug Discov 2016
120
22



Regulation of hepatic glucose metabolism in health and disease.
Max C Petersen, Daniel F Vatner, Gerald I Shulman. Nat Rev Endocrinol 2017
283
22

Management of type 2 diabetes: new and future developments in treatment.
Abd A Tahrani, Clifford J Bailey, Stefano Del Prato, Anthony H Barnett. Lancet 2011
318
22

Characterization of a novel glucokinase activator in rat and mouse models.
Min Lu, Pingping Li, Gautam Bandyopadhyay, William Lagakos, Walter E Dewolf, Taylor Alford, Mark Joseph Chicarelli, Lance Williams, Deborah A Anderson, Brian R Baer,[...]. PLoS One 2014
10
22

Insights into mechanism of glucokinase activation: observation of multiple distinct protein conformations.
Shenping Liu, Mark J Ammirati, Xi Song, John D Knafels, Jeff Zhang, Samantha E Greasley, Jeffrey A Pfefferkorn, Xiayang Qiu. J Biol Chem 2012
38
22

Molecular physiology of mammalian glucokinase.
P B Iynedjian. Cell Mol Life Sci 2009
203
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.